Related Experiment Video
Updated: Jun 13, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
[Characteristics of hepatitis and influenza antivirals: update 2009]
Ester Lopez-Suñé1, Montse Tuset, Montse Laguno
1Servicio de Farmacia, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic Universitari, Barcelona, España. eslopez@clinic.ub.es
Abstract:
This article aims to review hepatitis B and C and influenza infections and to summarise the main characteristics of the antiviral drugs available to treat those infections in adults. The review of each drug focuses on dosage depending on treatment indication, dosage adjustment in renal or hepatic impairment, main pharmacokinetic features and the most significant adverse effects and drug interactions.
More Related Videos
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Viral Hepatitis I: Introduction
Influenza
Antiviral Nucleoside Inhibitors